Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 87,701,562
- Total 13F value
- $3,644,892,889
- Share change
- +2,618,214
- SEC-reported price per share
- $41.56
- Number of holders
- 115
- Value change
- +$108,159,345
- Number of buys
- 64
- Number of sells
- 30
- Shares outstanding
- 4,389,099
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
115
Top holders
10
RLAY full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75943R102
Recent filing periods:
Ownership snapshot
Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F
Lead comparable stake: 636%
Showing 1-6 of 15 holder rows.
Quick read
SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 636%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership
Top 5
SB INVESTMENT ADVISERS (UK) LTD
636%
TRV GP III, LLC
240%
BAILLIE GIFFORD & CO
129%
FMR LLC
110%
Casdin Capital, LLC
87%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
636%
|
$1,188,472,000
27,904,963 shares
|
— | 30 Sep 2020 |
| TRV GP III, LLC |
13F
Company
|
240%
|
$449,372,000
10,551,115 shares
|
— | 30 Sep 2020 |
| BAILLIE GIFFORD & CO |
13F
Company
|
129%
|
$42,506,000
5,664,921 shares
|
— | 30 Sep 2020 |
| FMR LLC |
13F
Company
|
110%
|
$205,109,000
4,815,879 shares
|
— | 30 Sep 2020 |
| Casdin Capital, LLC |
13F
Company
|
87%
|
$162,221,000
3,808,894 shares
|
— | 30 Sep 2020 |
| BVF INC/IL |
13F
Company
|
77%
|
$143,885,000
3,378,380 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
115
Shares
87,701,562
Rows available
115
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
94
Q4 2020 holders
115
Holder diff
21
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend